Dexamethasone exposure accelerates endochondral ossification of chick embryos via angiogenesis

Toxicological Sciences

Volumn 149, Issue 1, 2016, Pages 167-177

  Cheng, Xin ^a   Yan, Yu ^a   Chen, Jian Long ^a   Ma, Zheng Lai ^a   Yang, Ren Hao ^a   Wang, Guang ^a   Chuai, Manli ^b   Ka Ho Lee, Kenneth ^c   Yang, Xuesong ^a,d  

^a JINAN UNIVERSITY   (China)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d JINAN UNIVERSITY   (China)

Author keywords

angiogenesis; chick embryos; Dexamethasone; mineralization; osteogenesis

Indexed keywords

COLLAGEN TYPE 10; COLLAGEN TYPE 10 ALPHA1; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

3T3 CELL LINE; ANGIOGENESIS; ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHICK EMBRYO; CHORIOALLANTOIS; COLONY FORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENCHONDRAL OSSIFICATION; GASTRULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; LONG BONE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PHALANX; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VITELLINE MEMBRANE; ANIMAL; CELL CULTURE; DRUG EFFECTS; PHYSIOLOGY;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL PROLIFERATION; CELLS, CULTURED; CHICK EMBRYO; DEXAMETHASONE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS;

EID: 84960090678     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfv227     Document Type: Article

References (40)

1. Ahmed, S. F., Wallace, W. H., Crofton, P. M., Wardhaugh, B., Magowan, R., and Kelnar, C. J. (1999). Short-term changes in lower leg length in children treated for acute lymphoblastic leukaemia. J. Pediatr. Endocrinol. Metab. 12, 75-80.
2. Azziz, R., and Ladda, R. L. (1990). Dexamethasone receptor levels in palatal and lung fibroblasts of adult A/J and C57BL/6J mice: relationship to glucocorticoid-induced cleft palate. Cleft Palate J. 27, 388-391; discussion 392.
3. Barnes, P. J. (1998). Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. (Lond.) 94, 557-572.
4. Bentovim, L., Amarilio, R., and Zelzer, E. (2012). HIF1alpha is a central regulator of collagen hydroxylation and secretion under hypoxia during bone development. Development 139, 4473-4483.
5. Canalis, E. (2005). Mechanisms of glucocorticoid action in bone. Curr. Osteoporos. Rep. 3, 98-102.
6. Carbone, D. L., Zuloaga, D. G., Hiroi, R., Foradori, C. D., Legare, M. E., and Handa, R. J. (2012). Prenatal dexamethasone exposure potentiates diet-induced hepatosteatosis and decreases plasma IGF-I in a sex-specific fashion. Endocrinology 153, 295-306.
7. Carmeliet, P. (2003). Angiogenesis in health and disease. Nat. Med. 9, 653-660.
8. Cheng, X., Chen, J. L., Ma, Z. L., Zhang, Z. L., Lv, S., Mai, D. M., Liu, J. J., Chuai, M., Lee, K. K., Wan, C., et al. (2014). Biphasic influence of dexamethasone exposure on embryonic vertebrate skeleton development. Toxicol. Appl. Pharmacol. 281, 19-29.
9. Cheng, X., Luo, R., Wang, G., Xu, C. J., Feng, X., Yang, R. H., Ding, E., He, Y. Q., Chuai, M., Lee, K. K., et al. (2015). Effects of 2, 5-hexanedione on angiogenesis and vasculogenesis in chick embryos. Reprod. Toxicol. 51, 79-89.
10. Cheng, X., Wang, G., Ma, Z. L., Chen, Y. Y., Fan, J. J., Zhang, Z. L., Lee, K. K., Luo, H. M., and Yang, X. (2012). Exposure to 2, 5-hexanedione can induce neural malformations in chick embryos. Neurotoxicology 33, 1239-1247.
11. Costa, E. V., Jimenez, G. C., Barbosa, C. T., and Nogueira, R. A. (2013). Fractal analysis of extra-embryonic vascularization in Japanese quail embryos exposed to extremely low frequency magnetic fields. Bioelectromagnetics 34, 114-121.
12. Hamburger, V., and Hamilton, H. L. (1992). A series of normal stages in the development of the chick embryo. 1951. Dev. Dyn. 195, 231-272.
13. He, Y. Q., Li, Y., Wang, X. Y., He, X. D., Jun, L., Chuai, M., Lee, K. K., Wang, J., Wang, L. J., and Yang, X. (2014). Dimethyl phenyl piperazine iodide (DMPP) induces glioma regression by inhibiting angiogenesis. Exp. Cell. Res. 320, 354-364.
14. Ishida, Y., and Heersche, J. N. (1998). Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J. Bone Miner. Res. 13, 1822-1826.
15. Joanny, E., Ding, Q., Gong, L., Kong, P., Saklatvala, J., and Clark, A. R. (2012). Anti-inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on upregulation of dual specificity phosphatase 1. Br. J. Pharmacol. 165, 1124-1136.
16. Kanczler, J. M., and Oreffo, R. O. (2008). Osteogenesis and angiogenesis: the potential for engineering bone. Eur. Cell. Mater. 15, 100-114.
17. Kigami, R., Sato, S., Tsuchiya, N., Yoshimakai, T., Arai, Y., and Ito, K. (2013). FGF-2 angiogenesis in bone regeneration within critical-sized bone defects in rat calvaria. Implant Dent. 22, 422-427.
18. Kronenberg, H. M. (2003). Developmental regulation of the growth plate. Nature 423, 332-336.
19. Lu, W. H., Wang, G., Li, Y., Li, S., Song, X. Y., Wang, X. Y., Chuai, M., Lee, K. K., Cao, L., and Yang, X. (2014). Autophagy functions on EMT in gastrulation of avian embryo. Cell Cycle 13, 2752-2764.
20. Mansukhani, A., Bellosta, P., Sahni, M., and Basilico, C. (2000). Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Cell Biol. 149, 1297-1308.
21. Meyer-Bahlburg, H. F., Dolezal, C., Baker, S. W., Carlson, A. D., Obeid, J. S., and New, M. I. (2004). Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone. J. Clin. Endocrinol. Metab. 89, 610-614.
22. Mushtaq, T., Farquharson, C., Seawright, E., and Ahmed, S. F. (2002). Glucocorticoid effects on chondrogenesis, differentiation and apoptosis in the murine ATDC5 chondrocyte cell line. J. Endocrinol. 175, 705-713.
23. O'Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C., and Weinstein, R. S. (2004). Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145, 1835-1841.
24. Olivares-Navarrete, R., Hyzy, S. L., Gittens, R. A. S., Schneider, J. M., Haithcock, D. A., Ullrich, P. F., Slosar, P. J., Schwartz, Z., and Boyan, B. D. (2013). Rough titanium alloys regulate osteoblast production of angiogenic factors. Spine J. 13, 1563-1570.
25. Olney, R. C. (2009). Mechanisms of impaired growth: effect of steroids on bone and cartilage. Horm. Res 72(Suppl 1), 30-35.
26. Pfander, D., Kobayashi, T., Knight, M. C., Zelzer, E., Chan, D. A., Olsen, B. R., Giaccia, A. J., Johnson, R. S., Haase, V. H., and Schipani, E. (2004). Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development. Development 131, 2497-2508.
27. Polverini, P. J. (2002). Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities. J. Dent. Educ. 66, 962-975.
28. Provot, S., and Schipani, E. (2005). Molecular mechanisms of endochondral bone development. Biochem. Biophys. Res. Commun. 328, 658-665.
29. Raff, H. (2004). Neonatal dexamethasone therapy: shortand long-term consequences. Trends Endocrinol. Metab. 15, 351-352.
30. Schmitz, N., Laverty, S., Kraus, V. B., and Aigner, T. (2010). Basic methods in histopathology of joint tissues. Osteoarthritis Cartilage 18(Suppl 3), S113-S116.
31. Shibuya, M. (2006). Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J. Biochem. Mol. Biol. 39, 469-478.
32. Siamblis, D., Karnabatidis, D., Hatjikondi, O., Kalogeropoulou, C., Kardamakis, D., and Dimopoulos, J. (1996). A novel radiological approach for the experimental study of angiogenesis: angiography of the chick embryo and its chorioallantoic membrane. Eur. J. Radiol. 21, 220-224.
33. Silbermann, M., and Maor, G. (1978). Mechanisms of glucocorticoid-induced growth retardation: impairment of cartilage mineralization. Acta Anat. (Basel) 101, 140-149.
34. Silbermann, M., Kadar, T., and Hornung, G. (1977). Corticosteroid-induced changes in glucose metabolism of chondrocytes. Histochemistry 50, 327-335.
35. Smith, E. L., Kanczler, J. M., and Oreffo, R. O. (2013). A new take on an old story: chick limb organ culture for skeletal niche development and regenerative medicine evaluation. Eur. Cell Mater. 26, 91-106; discussion 106.
36. Tsang, W. P., Shu, Y., Kwok, P. L., Zhang, F., Lee, K. K., Tang, M. K., Li, G., Chan, K. M., Chan, W. Y., and Wan, C. (2013). CD146+ human umbilical cord perivascular cells maintain stemness under hypoxia and as a cell source for skeletal regeneration. PLoS One 8, e76153.
37. Wallner, C., Schira, J., Wagner, J. M., Schulte, M., Fischer, S., Hirsch, T., Richter, W., Abraham, S., Kneser, U., Lehnhardt, M., et al. (2015). Application of VEGFA and FGF-9 enhances angiogenesis, osteogenesis and bone remodeling in type 2 diabetic long bone regeneration. PLoS One 10, e0118823.
38. Warner, J. O. (1995). Review of prescribed treatment for children with asthma in 1990. BMJ 311, 663-666.
39. Xia, X., Kar, R., Gluhak-Heinrich, J., Yao, W., Lane, N. E., Bonewald, L. F., Biswas, S. K., Lo, W. K., and Jiang, J. X. (2010). Glucocorticoid-induced autophagy in osteocytes. J. Bone Miner. Res. 25, 2479-2488.
40. Zelzer, E., and Olsen, B. R. (2005). Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr. Top. Dev. Biol. 65, 169-187.